These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1358580)

  • 1. The pharmacokinetics of 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rats.
    Epemolu OR; Singh S; Hider RC; Damani LA
    Drug Metab Dispos; 1992; 20(5):736-41. PubMed ID: 1358580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and pharmacokinetics of 1-(2'-trimethylacetoxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP117) in the rat.
    Choudhury R; Epemolu RO; Rai BL; Hider RC; Singh S
    Drug Metab Dispos; 1997 Mar; 25(3):332-9. PubMed ID: 9172951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of representative 3-hydroxypyridin-4-ones in rabbits: CP20 and CP94.
    Fredenburg AM; Wedlund PJ; Skinner TL; Damani LA; Hider RC; Yokel RA
    Drug Metab Dispos; 1993; 21(2):255-8. PubMed ID: 8097694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of two isomeric beta-d-glucosiduronic acids derived from 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rat liver homogenate incubates.
    Liu DY; Liu ZD; Piyamongkol S; Lu SL; Hider RC
    J Pharm Pharmacol; 2002 Jul; 54(7):951-7. PubMed ID: 12162714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicokinetics of deltamethrin and its 4'-HO-metabolite in the rat.
    Anadón A; Martinez-Larrañaga MR; Fernandez-Cruz ML; Diaz MJ; Fernandez MC; Martinez MA
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):8-16. PubMed ID: 8917670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary metabolic profiles in human and rat of 1,2-dimethyl- and 1,2-diethyl-substituted 3-hydroxypyridin-4-ones.
    Singh S; Epemolu RO; Dobbin PS; Tilbrook GS; Ellis BL; Damani LA; Hider RC
    Drug Metab Dispos; 1992; 20(2):256-61. PubMed ID: 1352218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the anti-AIDS drug 2',3'-dideoxyinosine in the rat.
    Ray GF; Mason WD; Badr MZ
    Drug Metab Dispos; 1990; 18(5):654-8. PubMed ID: 1981715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of iron overload on the metabolism and urinary recovery of 3-hydroxypyridin-4-one chelating agents in the rat.
    Choudhury R; Singh S
    Drug Metab Dispos; 1995 Mar; 23(3):314-20. PubMed ID: 7628295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators.
    Yokel RA; Fredenburg AM; Meurer KA; Skinner TL
    Drug Metab Dispos; 1995 Oct; 23(10):1178-80. PubMed ID: 8654208
    [No Abstract]   [Full Text] [Related]  

  • 11. Contrasting interspecies efficacy and toxicology of 1,2-diethyl-3-hydroxypyridin-4-one, CP94, relates to differing metabolism of the iron chelating site.
    Porter JB; Abeysinghe RD; Hoyes KP; Barra C; Huehns ER; Brooks PN; Blackwell MP; Araneta M; Brittenham G; Singh S
    Br J Haematol; 1993 Sep; 85(1):159-68. PubMed ID: 8251385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary and urinary metabolic profiles of 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in the rat.
    Lu SL; Gosriwatana I; Liu DY; Liu ZD; Mallet AI; Hider RC
    Drug Metab Dispos; 2000 Aug; 28(8):873-9. PubMed ID: 10901694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of (-)-carbovir in rats. Evidence for nonlinear elimination.
    Brouwer KR; St Claire RL; Lagarde J; Patanella JE; Walsh JS; Miwa GT
    Drug Metab Dispos; 1990; 18(6):1078-83. PubMed ID: 1981516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
    Lee P; Mohammed N; Marshall L; Abeysinghe RD; Hider RC; Porter JB; Singh S
    Drug Metab Dispos; 1993; 21(4):640-4. PubMed ID: 8104123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of a new antiinfective agent 1,3-di(4-imidazolino-2-methoxyphenoxy)propane in male rats.
    Bekersky I; Puhl RJ; Hanson G; Mong S
    Drug Metab Dispos; 1993; 21(6):1017-21. PubMed ID: 7905379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
    Grubb MF; Wong YN; Burcham DL; Saxton PL; Quon CY; Huang SM
    Drug Metab Dispos; 1994; 22(5):709-12. PubMed ID: 7835221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of tetrabenazine and its major metabolite in man and rat. Bioavailability and dose dependency studies.
    Mehvar R; Jamali F; Watson MW; Skelton D
    Drug Metab Dispos; 1987; 15(2):250-5. PubMed ID: 2882986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose pharmacokinetics and bioavailability of glucosamine in the rat.
    Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F
    J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.